Literature DB >> 7211675

Hematocrit and risk of coronary heart disease: the Puerto Rico Health Program.

P D Sorlie, M R Garcia-Palmieri, R Costas, R J Havlik.   

Abstract

Hematocrit was determined in 2555 rural and 6151 urban men age 45 to 64 years participating in the Puerto Rico Health Program, a prospective epidemiologic study of coronary artery disease (CAD). These participants were reexamined three additional times and mortality by cause and coronary heart disease (CHD) morbidity were carefully documented for 8 years of follow-up. Since hematocrit (Hct) is an indirect measure of blood viscosity, its value an an independent risk factor of CHD was evaluated. Within the Puerto Rican cohort, Hct is slightly lower in older age groups, and appears slightly lower in the rural than in the urban area. In the rural area 4.6% had Hct values below 40%; in the urban area 3.0% were below 40%. A higher Hct level was associated with cigarette smoking, higher relative weight, higher blood pressure, and higher serum cholesterol. An elevated Hct level was also associated with an increased risk of myocardial infarction (MI), coronary insufficiency or CHD death in the urban area. Incidence of MI, coronary insufficiency, or CHD death was more than double in the high hematocrit group (Hct greater than 49%) compared to the low group (Hct less than 42%). Using a multivariate logistic function, the relationship remained statistically significant after adjustment for the above mentioned risk factors. These results provide further insight concerning the issue of the potential impact of elevated Hct as an independent risk factor contributing to the incidence of CHD mortality and morbidity.

Entities:  

Mesh:

Year:  1981        PMID: 7211675     DOI: 10.1016/0002-8703(81)90136-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  21 in total

Review 1.  Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma.

Authors:  Gilberto Paz-Filho; Julio Licinio; Ma-Li Wong
Journal:  Braz J Psychiatry       Date:  2010-06       Impact factor: 2.697

2.  Haemorheology in patients with branch retinal vein occlusion with and without risk factors.

Authors:  A Remky; O Arend; F Jung; H Kiesewetter; M Reim; S Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

Review 3.  Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update.

Authors:  Mohammad Madjid; Omid Fatemi
Journal:  Tex Heart Inst J       Date:  2013

4.  Hemoglobin concentration and risk of arterial and venous thrombosis in 1.5 million Swedish and Danish blood donors.

Authors:  Malin Hultcrantz; Anton Modlitba; Senthil K Vasan; Arvid Sjölander; Klaus Rostgaard; Ola Landgren; Henrik Hjalgrim; Henrik Ullum; Christian Erikstrup; Sigurdur Y Kristinsson; Gustaf Edgren
Journal:  Thromb Res       Date:  2019-12-20       Impact factor: 3.944

5.  A critical analysis of testosterone supplementation therapy and cardiovascular risk in elderly men.

Authors:  Jason Scovell; Ranjith Ramasamy; Jason R Kovac
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

6.  Acute hemoconcentration during psychological stress: assessment of hemorheologic factors.

Authors:  S M Patterson; A L Marsland; S B Manuck; M Kameneva; M F Muldoon
Journal:  Int J Behav Med       Date:  1998

7.  Effect of nitroglycerin on blood rheology in healthy subjects.

Authors:  W Brügger; P Imhof; P Müller; P Moser; F Reubi
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Hematocrit and stroke. A case-control study.

Authors:  O Ponari; M Squeri; A Mombelloni; A Catamo; S Tardio; G Moretti
Journal:  Ital J Neurol Sci       Date:  1984-12

9.  Ischaemic heart disease: association with haematocrit in the British Regional Heart Study.

Authors:  G Wannamethee; A G Shaper; P H Whincup
Journal:  J Epidemiol Community Health       Date:  1994-04       Impact factor: 3.710

Review 10.  Androgens and erythropoiesis: past and present.

Authors:  S Shahani; M Braga-Basaria; M Maggio; S Basaria
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.